These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26146829)

  • 1. The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases: A Meta-Analysis of Prospective Cohort Studies.
    Hou TY; Wang SH; Liang SX; Jiang WX; Luo DD; Huang DH
    PLoS One; 2015; 10(7):e0131602. PubMed ID: 26146829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of (1 → 3)-β-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease: A meta-analysis.
    Shi XY; Liu Y; Gu XM; Hao SY; Wang YH; Yan D; Jiang SJ
    Respir Med; 2016 Aug; 117():48-53. PubMed ID: 27492513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis.
    Lu Y; Chen YQ; Guo YL; Qin SM; Wu C; Wang K
    Intern Med; 2011; 50(22):2783-91. PubMed ID: 22082890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).
    Lamoth F; Cruciani M; Mengoli C; Castagnola E; Lortholary O; Richardson M; Marchetti O;
    Clin Infect Dis; 2012 Mar; 54(5):633-43. PubMed ID: 22198786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.
    Hammarström H; Kondori N; Friman V; Wennerås C
    Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):917-25. PubMed ID: 25573536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of plasma (1, 3)-beta-D glucan assay for invasive fungal infections in patients with hematological disorders].
    Liu F; Wu T; Cai P; Liu Y; Lu Y; Zhou JR; Yang F; Liu Q; Gao YQ; Luo RM; Zhang JP; Sun Y; Cao XY; Yin YM; Zhao YL; Wang JB; Tong CR; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1043-6. PubMed ID: 19698256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.
    Alexander BD; Smith PB; Davis RD; Perfect JR; Reller LB
    J Clin Microbiol; 2010 Nov; 48(11):4083-8. PubMed ID: 20720025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.
    Onishi A; Sugiyama D; Kogata Y; Saegusa J; Sugimoto T; Kawano S; Morinobu A; Nishimura K; Kumagai S
    J Clin Microbiol; 2012 Jan; 50(1):7-15. PubMed ID: 22075593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.
    Koo S; Bryar JM; Page JH; Baden LR; Marty FM
    Clin Infect Dis; 2009 Dec; 49(11):1650-9. PubMed ID: 19863452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of plasma beta-Glucan in early diagnosis of invasive fungal infection in children].
    Zhao L; Tang JY; Wang Y; Zhou YF; Chen J; Li BR; Xue HL
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):905-8. PubMed ID: 20113658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.
    Karageorgopoulos DE; Vouloumanou EK; Ntziora F; Michalopoulos A; Rafailidis PI; Falagas ME
    Clin Infect Dis; 2011 Mar; 52(6):750-70. PubMed ID: 21367728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Efficacy of Serum 1,3-β-D-glucan for Invasive Fungal Infection: An Update Meta-Analysis Based on 37 Case Or Cohort Studies.
    Xiaoling L; Tingyu T; Caibao H; Tian Z; Changqin C
    Open Med (Wars); 2018; 13():329-337. PubMed ID: 30211316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Utility of galactomannan enzyme immunoassay and (1,3)beta-D-glucan assay in invasive fungal infection].
    Yu J; Li RY; Gao LJ; Lu QY; Wang XH
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):371-4. PubMed ID: 20367931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies--high frequency of false-positive results and their analysis.
    Racil Z; Kocmanova I; Lengerova M; Weinbergerova B; Buresova L; Toskova M; Winterova J; Timilsina S; Rodriguez I; Mayer J
    J Med Microbiol; 2010 Sep; 59(Pt 9):1016-1022. PubMed ID: 20488937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical viability of Fungitell, a new (1→3)-β-D: -glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan.
    Yoshida K; Shoji H; Takuma T; Niki Y
    J Infect Chemother; 2011 Aug; 17(4):473-7. PubMed ID: 21210174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
    Zeng SY; Liu T; Meng WT; Chen YN
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants.
    Zhao D; Qiu G; Luo Z; Zhang Y
    PLoS One; 2015; 10(4):e0123907. PubMed ID: 25874376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
    Ostrosky-Zeichner L; Alexander BD; Kett DH; Vazquez J; Pappas PG; Saeki F; Ketchum PA; Wingard J; Schiff R; Tamura H; Finkelman MA; Rex JH
    Clin Infect Dis; 2005 Sep; 41(5):654-9. PubMed ID: 16080087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Odabasi Z; Mattiuzzi G; Estey E; Kantarjian H; Saeki F; Ridge RJ; Ketchum PA; Finkelman MA; Rex JH; Ostrosky-Zeichner L
    Clin Infect Dis; 2004 Jul; 39(2):199-205. PubMed ID: 15307029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.
    Acosta J; Catalan M; del Palacio-Pérez-Medel A; Montejo JC; De-La-Cruz-Bértolo J; Moragues MD; Pontón J; Finkelman MA; del Palacio A
    Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):721-31. PubMed ID: 21811868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.